SAN JOSE, Calif.--(BUSINESS WIRE)--VitalConnect ®, Inc., a leader in remote and in-hospital monitoring biosensor technology, announced today it has launched its VitalPatch RTM mobile cardiac telemetry ...
Growth is driven by rising cardiovascular disease, telehealth adoption, and advances in wearable ECG devices, implantable monitors, AI analytics, and cloud platforms. North America leads, while ...
U.S. Remote Cardiac Monitoring Market to Reach USD 5.02 Billion and Europe USD 4.08 Billion by 2035 as AI Arrhythmia Detection, CPT Reimbursement, and Home Care Transitions Drive Growth.Austin, Texas, ...
Empowering clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move Telemetry overuse can burden frontline teams ...
Please provide your email address to receive an email when new articles are posted on . Long-term continuous ECG monitoring with human oversight outperformed an artificial intelligence-based mobile ...
Health technology company Philips has introduced a new telemetry platform to address the challenge of staffing shortages and alarm management. A key feature is Telemetry Monitor 5500, a "data-driven ...
Cardiac Health is Top of Mind. The Quest to ‘Zero’ Avoidable Cardiac-Related Deaths Continues. Cardiac disease is one of the top health concerns in the United States. According to the Centers for ...
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Big news for the first startup shepherded by the West Wireless Health Institute: The FDA has greenlit Corventis' Nuvant system, a mobile cardiac telemetry system. The 510(k) clearance for Nuvant ...
To detect "silent" or new cardiac abnormalities, all patients hospitalized for stroke should receive continuous cardiac rhythm monitoring (telemetry) for at least the first 24 hours after the stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results